INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

82,071 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
BB
Barker Richard B.EVP and CFO
NENoble Corp plc
Option exercise
M—
7,849 sh
Jan 26, 2026Jan 28, 2026
Page 1654 of 2052
← PrevNext →
traded Jan 26, 2026
+2d
SEC Form 4

Evidence

9
AI
Asner Scott IanDirector
NONENONEFERRELLGAS PARTNERS L P
Grant or award
A—
3,796 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
DJ
Drappa JornChief Medical Officer
ALMSALUMIS INC.
Grant or award
A—
221.4K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
RR
Roeder Charles RPresident - RV
PATKPATRICK INDUSTRIES INC
Tax withholding
F$32K
246 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
GM
Goldstein David MChief Scientific Officer
ALMSALUMIS INC.
Grant or award
A—
216.7K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
DW
Davies WilliamEXECUTIVE VP, GLOBAL CIO
AMPAMERIPRISE FINANCIAL INC
Disposition to issuer
D$49K
98 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
FS
Forte SteveEVP, CHIEF FINANCIAL OFFICER
RPTXRepare Therapeutics Inc.
Disposition to issuer
D—
200.0K sh
Jan 28, 2026Jan 28, 2026
traded Jan 28, 2026
+0dSEC Form 4

Evidence

9
BM
Brockman Dawn M.SVP AND CONTROLLER
AMPAMERIPRISE FINANCIAL INC
Tax withholding
F$11K
22 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
LE
Lee David EricVICE CHAIR, WINTRUST FINANCIAL
WTFCWINTRUST FINANCIAL CORP
Tax withholding
F$31K
215 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
WZ
Wold Dyan Z.VP, Controller and CAO
SRESEMPRA
Grant or award
A—
310 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

9
MJ
McClintock Douglas JSEVP
FFICFLUSHING FINANCIAL CORP
Option exercise
M—
2,000 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

9
MG
Magno Maria GeorgiaChief Legal Officer
BKRBaker Hughes Co
Tax withholding
F$44K
779 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
WC
Wiechmann Andrew C.Chief Financial Officer
MSCIMSCI Inc.
Grant or award
A—
5,639 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
SJ
Sbragia JohnSVP, Engineering and Quality
GATXGATX CORP
Tax withholding
F$34K
186 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
MJ
Munari Alvise J.Chief Product Officer
MSCIMSCI Inc.
Grant or award
A—
6,042 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
SL
Sedgwick Karen LExecutive VP and CFO
SRESEMPRA
Grant or award
A—
2,166 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

9
MN
Mac Ban Ryan NorrisChief Revenue Officer
CFLTConfluent, Inc.
Grant or award
A—
59.9K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
SS
Schuckman Matthew StevenExecutive Vice President
CASSCASS INFORMATION SYSTEMS INC
Tax withholding
F$24K
548 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

8
WA
Winn Caroline AnnExecutive Vice President
SRESEMPRA
Tax withholding
F$137K
1,575 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

8
LL
Larroque Alexander LisaSVP, Corp Affairs and HR
SRESEMPRA
Tax withholding
F$50K
577 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

8
SL
Sedgwick Karen LExecutive VP and CFO
SRESEMPRA
Tax withholding
F$155K
1,783 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

7
FS
Fendley Steven S.President, US Division
KTOSKRATOS DEFENSE & SECURITY SOLUTIONS, INC.
Open-market sale · 10b5-1 plan
SELL$318K
2,968 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

7
FS
Fendley Steven S.President, US Division
KTOSKRATOS DEFENSE & SECURITY SOLUTIONS, INC.
Open-market sale · 10b5-1 plan
SELL$437K
4,032 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

7
AK
Adamson KeelanDirector, PRESIDENT AND CEO
RIGTransocean Ltd.
Open-market sale · 10b5-1 plan
SELL$293K
58.7K sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

5
GJ
Gutowski Robert J.General Counsel
MSCIMSCI Inc.
Grant or award
A—
3,624 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

5
LL
Larroque Alexander LisaSVP, Corp Affairs and HR
SRESEMPRA
Grant or award
A—
700 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

5
DJ
Donovan James JosephChief Lending Officer/FSVP
UNTYUNITY BANCORP INC /NJ/
Tax withholding
F$7,065
135 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

5
WZ
Wold Dyan Z.VP, Controller and CAO
SRESEMPRA
Tax withholding
F$22K
254 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

4
AK
Adamson KeelanDirector, PRESIDENT AND CEO
RIGTransocean Ltd.
Open-market sale · 10b5-1 plan
SELL$114K
22.8K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

1
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M$1.15M
7,875 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

1
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M$1.72M
14.6K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
3,000 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
102.8K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
8,335 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M—
14.6K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence